Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Biomerica (BMRA) EBIT (2016 - 2026)

Biomerica's EBIT history spans 17 years, with the latest figure at -$1.3 million for Q1 2026.

  • Quarterly results put EBIT at -$1.3 million for Q1 2026, down 7.27% from a year ago — trailing twelve months through Feb 2026 was -$5.4 million (down 312.84% YoY), and the annual figure for FY2025 was -$5.1 million, down 511.95%.
  • EBIT for Q1 2026 was -$1.3 million at Biomerica, up from -$1.4 million in the prior quarter.
  • In the past five years, EBIT ranged from a high of $6.1 million in Q2 2024 to a low of -$2.1 million in Q3 2022.
  • The 5-year median for EBIT is -$1.4 million (2025), against an average of -$986168.8.
  • The sharpest move saw EBIT crashed 1435.83% in 2023, then surged 431.48% in 2024.
  • Year by year, EBIT stood at -$1.7 million in 2022, then rose by 3.48% to -$1.6 million in 2023, then soared by 38.25% to -$993000.0 in 2024, then tumbled by 38.27% to -$1.4 million in 2025, then grew by 5.46% to -$1.3 million in 2026.
  • According to Business Quant data, EBIT over the past three periods came in at -$1.3 million, -$1.4 million, and -$1.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.